<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30298090</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1687-8450</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>2018</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Journal of oncology</Title>                <ISOAbbreviation>J Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Outcomes Following Salvage Radiation and Systemic Therapy for Isolated Locoregional Recurrence of Breast Cancer after Mastectomy: Impact of Constructed Biologic Subtype.</ArticleTitle>            <Pagination>                <MedlinePgn>4736263</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/4736263</ELocationID>            <Abstract>                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">This study examines factors associated with outcomes following salvage radiation and systemic therapy for breast cancer patients who developed isolated locoregional recurrence (ILRR) after mastectomy alone, while focusing on the prognostic significance of constructed biologic subtype in this setting.</AbstractText>                <AbstractText Label="Methods and Materials" NlmCategory="UNASSIGNED">269 postmastectomy patients in total treated for ILRR were included. Cumulative incidence of locoregional control (LRC), distant metastasis (DM)-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) were calculated using Kaplan-Meier method. For statistical analysis, biologic subtypes were constructed from hormonal receptors (Rec) and HER2, consisting of Rec+/HER2-, Rec+/HER2+, Rec-/HER2+, and Rec-/HER2-. The association of clinic-pathological and treatment-related parameters with outcomes was evaluated using a Cox regression model.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">At a median follow-up of 65 months, 56 (20.8%) patients failed to secure LRC after radiotherapy, and 165 patients (61.3%) developed DM. Overall, the actuarial 5-year LRC, DMFS, DFS, and OS rate was 77.3%, 45.6%, 43.9%, and 66.8%, respectively. Multivariate analysis revealed that constructed biologic subtype represented the most significant prognostic factor for any outcome. Compared to patients with Rec+/HER2- disease, those with Rec-/HER2- had significantly poorer 5-year LRC (84.2% versus 58.3%, HR = 4.36, P &lt; 0.001) and worse survivals including 5-year DMFS (63.0% versus 15.8%, HR = 4.28, P &lt; 0.001), DFS (59.7% versus 13.6%, HR=3.92, P &lt; 0.001), and OS (87.8% versus 22.3%, HR = 8.55, P &lt; 0.001). Other factors associated with reduced LRC were no radical surgery and involved field irradiation alone, whereas factors associated with poor survivals included positive nodes at primary diagnosis and regional recurrence.</AbstractText>                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Constructed biologic subtypes remained to be predictive of both disease control and survivals after salvage radiation for postmastectomy ILRR. Notably, Rec-/HER2- patients were demonstrated to be at high risk of locoregional failure and subsequent DM and tended to have worse survivals despite salvage therapies.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Xiaofang</ForeName>                    <Initials>X</Initials>                    <Identifier Source="ORCID">0000-0002-2457-3474</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ma</LastName>                    <ForeName>Jinli</ForeName>                    <Initials>J</Initials>                    <Identifier Source="ORCID">0000-0001-6127-648X</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mei</LastName>                    <ForeName>Xin</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Zhaozhi</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yu</LastName>                    <ForeName>Xiaoli</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>Xiaomao</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Zhen</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shao</LastName>                    <ForeName>Zhimin</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>12</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Egypt</Country>            <MedlineTA>J Oncol</MedlineTA>            <NlmUniqueID>101496537</NlmUniqueID>            <ISSNLinking>1687-8450</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2003 Jul;10(6):628-34</RefSource>                <PMID Version="1">12839847</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2015 Jan-Feb;21(1):3-12</RefSource>                <PMID Version="1">25494903</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2008 Mar 20;26(9):1419-26</RefSource>                <PMID Version="1">18285604</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1453-7</RefSource>                <PMID Version="1">21168284</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiat Oncol. 2013 Jan 11;8:13</RefSource>                <PMID Version="1">23311297</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2008 Jun;17(3):302-8</RefSource>                <PMID Version="1">18082403</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2012 Feb;21(1):50-7</RefSource>                <PMID Version="1">21865043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2014 Feb;15(2):156-63</RefSource>                <PMID Version="1">24439313</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Oncol. 2010 Feb;33(1):23-7</RefSource>                <PMID Version="1">19704369</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 Nov 3;6(34):36860-9</RefSource>                <PMID Version="1">26416456</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):299-310</RefSource>                <PMID Version="1">2061107</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2014 Jun;14(3):198-204</RefSource>                <PMID Version="1">24485702</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 2006 May;79(2):147-55</RefSource>                <PMID Version="1">16647152</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):57-64</RefSource>                <PMID Version="1">24161421</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2011 Oct;18(4):252-8</RefSource>                <PMID Version="1">20449777</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2002 Feb;11(1):53-7</RefSource>                <PMID Version="1">14965646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Surg. 2006 Oct;203(4):469-74</RefSource>                <PMID Version="1">17000389</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1456-64</RefSource>                <PMID Version="1">18692329</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30298090</ArticleId>            <ArticleId IdType="doi">10.1155/2018/4736263</ArticleId>            <ArticleId IdType="pmc">PMC6157175</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>